Similar articles

• [Practical aspects of pharmacokinetics in renal failure].

  Orzechowska-Juzwenko K, Janicki AG. Orzechowska-Juzwenko K, et al. Pol Tyg Lek. 1982 Oct 18;37(39):1181-4. Pol Tyg Lek. 1982. PMID: 7163064 Polish. No abstract available.
• [Pharmacokinetic bases of dosage adaptation of drugs in renal insufficiency].

  Lesne M. Lesne M. J Pharm Belg. 1988 May-Jun;43(3):212-32. J Pharm Belg. 1988. PMID: 3171871 French. No abstract available.
• Optimizing drug development and use in patients with kidney disease.

  Nolin TD, Arya V, Sitar DS, Pfister M. Nolin TD, et al. J Clin Pharmacol. 2011 May;51(5):628-30. doi: 10.1177/0091270011402500. J Clin Pharmacol. 2011. PMID: 21525394 No abstract available.
• Drug dosing adjustments in patients with chronic kidney disease.

  Munar MY, Singh H. Munar MY, et al. Am Fam Physician. 2007 May 15;75(10):1487-96. Am Fam Physician. 2007. PMID: 17555141 Review.
• [Hepatic clearance of drugs in kidney failure].

  Balant L. Balant L. Nephrologie. 1983;4(2):45-7. Nephrologie. 1983. PMID: 6136004 Review. French. No abstract available.